RafaelCanadas-ZizziasMD Certified Physician Investigator

Internal Medicine • Dallas, TX

Preventive Medicine, Endocrinology, Obesity Medicine & Nutrition

Medical Director at Galenos Research

Join to view full profile

Dr. Canadas-Zizzias is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Canadas-Zizzias' full profile

Already have an account?

Office
12201 Merit Drive
Suite 180
Dallas, TX 75251
Phone+1 972-385-9700

Fax+1 972-385-9921

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1994 - 1996
New York-Presbyterian/QueensInternship, Internal Medicine, 1993 - 1994
National University of Cuyo School of MedicineClass of 1990

Certifications & Licensure

TX State Medical License 1997 - 2024
MI State Medical License 1996 - 1997
American Board of Internal Medicine Internal Medicine
Association of Clinical Research ProfessionalsCertified Physician Investigator

Awards, Honors, & Recognition

Most Compassionate Doctor American Registry

Clinical Trials

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin Start of enrollment: 2002 Mar 01
Completed
Phase 3
Comparison of 4 Diets in the Management of Overweight Patients With Vascular Disease Start of enrollment: 2004 Sep 01
Terminated
Phase 4
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Extension Study for 2993-112 Start of enrollment: 2002 Sep 01
Completed
Phase 3
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes Start of enrollment: 2020 May 29
Active, not recruiting
Phase 3
Investigational Study of Delayed Release Metformin Start of enrollment: 2021 May 18
Suspended
Phase 3
Join now to see all

Publications & Presentations

PubMed

420 citations
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Carel W. le Roux, Arne Astrup, Ken Fujioka, Frank Greenway, David C.W. Lau
Lancet. 2017-04-08

Professional Memberships

American Medical Association - AMA
Member
American Diabetes Association - ADA
Member

Other Languages

Spanish

External Links

Association of Clinical Research Professionalshttp://www.acrpnet.org/
American Medical Associationhttp://www.ama-assn.org/ama